Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy in breast cancer: a systematic review and meta-analysis with focus on triple-negative subtype and immune-related adverse events

Abstract Objective To systematically evaluate the efficacy and safety of chemotherapy combined with PD-1/PD-L1 inhibitors in breast cancer, thereby informing clinical decision-making. Methods A comprehensive search was conducted in PubMed, Cochrane Library, Embase, CNKI, Wanfang, and VIP databases f...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aisaide Aikelaimu, Weiwei Li, Mirinsa Kaicaier, Shengjie Liu, Yuhan Zhang, Xueping Hou, Yuying Wang, Liyuan Ma, Weihua Jiang
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-01-01
Col·lecció:	BMC Cancer
Matèries:	Breast cancer PD-1 inhibitor PD-L1 inhibitor Chemotherapy Meta-analysis Efficacy
Accés en línia:	https://doi.org/10.1186/s12885-025-15521-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!